Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

Mingzhu Receives Nasdaq Delisting Notice Subject to Hearing Request

SHENZHEN, China, Feb. 15, 2025 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services...

NAVER D2SF Invests in “STUDIO LAB,” an AI-Powered E-Commerce Content Generation Startup

Leveraging multimodal AI to create high-quality product detail pages for e-commerce—completing texts, images, and layouts in 15–30 seconds Secured...

MicroCloud Hologram Inc. announces optimization of stacked sparse autoencoders through DeepSeek model

SHENZHEN, China, Feb. 14, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, they Announced the deep optimization...

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

SHANGHAI and NANJING, China and SAN JOSE, Calif., Feb. 14, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery,...

Inaugural Longines Hong Kong International Horse Show Unveiled: AsiaWorld-Expo Transforms into a Five-Star Equestrian Paradise, Delivering an Extraordinary Spectacle

HONG KONG, Feb. 14, 2025 /PRNewswire/ -- For the first time, the prestigious five-star international equestrian event with over 50 years of history in...